Masamoto Murakami

Professor

Ehime University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Masamoto Murakami is a faculty member at Ehime University in Japan. His research primarily focuses on the efficacy and safety of treatments for skin conditions, particularly through the modulation of immune responses and keratinocyte behavior. Recent publications include studies on the therapeutic effects of brodalumab and the role of IL-33 in skin barrier integrity and psoriasis pathology.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

Yoichi Mizukami

Prof

Yamaguchi University

JAPAN

View details

Kazuki Yatsuzuka

Assistant Professor

Ehime University

JAPAN

View details

Koji Sayama

JAPAN

View details

Kenji Watanabe

Yamaguchi University

JAPAN

View details

Yukari Okubo

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Masamoto Murakami

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Trehalose Prevents IL-4/IL-13–Induced Skin Barrier Impairment by Suppressing IL-33 Expression and Increasing NRF2 Activation in Human Keratinocytes In Vitro

Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial

Authors’ Reply to Wang et al., “Comment on ‘Efficacy and Safety of Brodalumab, an Anti‑interleukin‑17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16‑Week Results of a Randomized Clinical Trial’”

Nuclear IL-33 Plays an Important Role in EGFR-Mediated Keratinocyte Migration by Regulating the Activation of Signal Transducer and Activator of Transcription 3 and NF-κB

Research letter: A new fluorescent three‐dimensional and deep‐imaging technique for histological identification of individual tumor cells in extramammary Paget's disease

Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study

The use of certolizumab pegol to successfully treat generalized pustular psoriasis combined with psoriatic uveitis

A successful switch from guselkumab to tildrakizumab during the treatment of a patient with psoriasis vulgaris

TSLP Impairs Epidermal Barrier Integrity by Stimulating the Formation of Nuclear IL-33/Phosphorylated STAT3 Complex in Human Keratinocytes

EGFR ligands synergistically increase IL‐17A‐induced expression of psoriasis signature genes in human keratinocytes via IκBζ and Bcl3

Flare‐up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination

Successful treatment of psoriasis vulgaris with apremilast in a patient with decompensated cirrhosis

Nuclear IL-33 Plays an Important Role in IL-31‒Mediated Downregulation of FLG, Keratin 1, and Keratin 10 by Regulating Signal Transducer and Activator of Transcription 3 Activation in Human Keratinocytes

Response to 'Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)'.

Collaborators (5)

Yoichi Mizukami

Kazuki Yatsuzuka

Koji Sayama

Kenji Watanabe

Yukari Okubo

Make your next move.